[Immune-mediated pathogenesis and management of pediatric aplastic anemia]

[Article in Chinese]

Review

[Article in Chinese]

Yong-lan Huang et al. Zhonghua Er Ke Za Zhi. 2006 Feb.

. 2006 Feb;44(2):153-5.

No abstract available

Similar articles

[The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
Ganapiev AA, Golubovskaia IK, Zalialov IuR, Estrina MA, Afanas'ev BV. Ganapiev AA, et al. Ter Arkh. 2010;82(7):48-52. Ter Arkh. 2010. PMID: 20853609 Clinical Trial. Russian.
Immunosuppressive therapy vs. bone marrow transplant for severe aplastic anemia.
Abella E, Ravindranth Y. Abella E, et al. J Pediatr Hematol Oncol. 1997 Nov-Dec;19(6):533-4. doi: 10.1097/00043426-199711000-00009. J Pediatr Hematol Oncol. 1997. PMID: 9407941 No abstract available.
Current management of aplastic anemia.
Nicholls MD, Biggs JC, Atkinson K, Concannon AJ, Dodds AJ. Nicholls MD, et al. Aust N Z J Med. 1984 Apr;14(2):97-9. doi: 10.1111/j.1445-5994.1984.tb04266.x. Aust N Z J Med. 1984. PMID: 6383318 No abstract available.
[The treatment of the aplastic syndromes].
Gross R, Hellriegel KP, Zach J. Gross R, et al. Internist (Berl). 1971 Apr;12(4):186-91. Internist (Berl). 1971. PMID: 4928641 Review. German. No abstract available.
[Etiopathogenesis of aplastic anemia and of the severe form treated with immunosuppression and bone marrow transplantation].
Dulley FL, Lotério HA, Massumoto CM, Llacer PE, Chamone Dde A. Dulley FL, et al. Rev Hosp Clin Fac Med Sao Paulo. 1989 Jul-Aug;44(4):167-70. Rev Hosp Clin Fac Med Sao Paulo. 1989. PMID: 2696069 Review. Portuguese.